4 Day 3: Wet-Laboratory Microsurgical Training: Basic Principles for Working with Laboratory Animals



10.1055/b-0040-177318

4 Day 3: Wet-Laboratory Microsurgical Training: Basic Principles for Working with Laboratory Animals

Evgenii Belykh and Nikolay L. Martirosyan


Abstract


Microneurosurgical training using laboratory animals is often considered as a final preparatory step before performing microvascular anastomosis on a patient. Such training should begin with a training session on the use and care of laboratory animals according to the guidelines of the particular institution. This chapter does not replace such institutional training but is intended to reinforce and briefly summarize critical points about laboratory safety, animal care, animal handling, anesthesia, and general surgical approaches. It also provides summarized information that would be of use in each wet-laboratory training session.




4.1 Basic Principles of Working with Laboratory Animals


To begin training, one must first become familiar with the rules of the laboratory and with handling laboratory animals. One’s attitude toward laboratory animals must be as humane and respectful as it is to humans in acknowledgment of the sacrifice made.


In order to work with laboratory animals, an application for the work should be approved by an ethics committee at the institution. In many countries, there is a formal body (e.g., an institutional animal care and use committee) that supervises such work and ensures that it adheres to international standards. The researcher takes responsibility to ensure that the care of the animals is exemplary and, if necessary, may be obligated to take care of the animals personally, including feeding, watering, anaesthetizing during pain or distress, and promptly performing euthanasia, if needed.


Considering the necessity of information about handling laboratory animals and the relatively rare literature on this topic, we decided to provide essential principles that everyone who undergoes microsurgical training should know.



4.2 The Three “R” Principles


In most countries, researchers are guided by the three “R” principles for humane treatment of research animals that were proposed by William Moy Stratton Russell and Rex Leonard Burch in 1959. 1 These principles are referred to as reduction, refinement, and replacement. Reduction refers to methods that enable researchers to obtain comparable levels of information from fewer animals or to obtain more information from the same number of animals; refinement refers to methods that alleviate or minimize potential pain, suffering, or distress and enhance welfare for the animals used; and replacement is the practice of preferring to use nonanimal methods over animal methods whenever it is possible to achieve the same scientific aim.



4.3 Symptoms of Pain and Distress in Laboratory Animals


When working with laboratory animals, it is important to be able to recognize the signs of pain and distress that they may exhibit. Pain is defined as an unpleasant sensory and emotional experience associated with potential or actual tissue damage, or described in terms of such damage (from the International Association for the Study of Pain). Distress is defined as the biological responses that an animal exhibits in an attempt to cope with a threat to its homeostasis. 2 Signs of pain and distress in laboratory animals are presented in Table 4.1 and Fig. 4.1.

Fig. 4.1 Coding of facial expressions of pain in the laboratory mouse from the mouse grimace scale could be used to detect and understand the animal pain and distress. The grimaces are subjectively graded from 0 (not present) to 2 (severe) to make a global pain/no pain assessment. (Reproduced with permission from Langford DJ, Bailey AL, Chanda ML, et al. Coding of facial expressions of pain in the laboratory mouse. Nat Methods. 2010;7:447–449.)





























































































































Table 4.1 Potential signs associated with pain or distress in laboratory animals

Symptom


Laboratory animals

 

Mice


Rats


Rabbits


Decreased food and water consumption


+


+


+


Weight loss


+


+


+


Self-imposed isolation/hiding


+


+


+


Self-mutilation, gnawing at limbs


+


+


+


Rapid breathing


+


+


+


Opened-mouth breathing


+


+


+


Abdominal breathing


+


+


+


Grinding teeth



+


+


Biting/growling/aggression



+


+


Increased/decreased movement


+


+


+


Unkempt appearance (erected, matted, or dull coat)


+


+


+


Abnormal posture/positioning (e.g., head-pressing, hunched back)


+


+


+


Restless sleep




+


Tearing (including porphyrin staining), lack of blinking reflex



+


+


Dilated pupils




+


Muscle rigidity, lack of muscle tone


+


+


+


Dehydration/skin tenting/sunken eyes


+


+


+


Twitching, trembling, tremor


+


+


+


Vocalization (rare)


+


+


+


Redness or swelling around surgical site


+


+


+


Increased salivation




+


Source:Adapted from Office of Animal Care and Use: Guidelines for Pain and Distress in Laboratory Animals: Responsibilities, Recognition and Alleviation. Bethesda, MD: Office of Animal Care and Use, National Institutes of Health, 2015. Available at: https://oacu-oir-nih-gov.easyaccess2.lib.cuhk.edu.hk/animal-research-advisory-committee-guidelines.



4.4 Anesthesia


Appropriate pain relief and sedation, as well as proper care of laboratory animals, are the responsibility of the researcher. There are two primary ways to induce anesthesia: injection and inhalation. Injection can be performed via intravenous, intraperitoneal, or intramuscular (Fig. 4.2) routes.

Fig. 4.2 Rat anesthesia by intramuscular drug injection. Take rat by the tail and put it into the restriction device for easy and safe injection of drugs into the animal’s thigh muscles.

The mode of anesthesia is usually chosen based on the availability of a certain drug and the peculiarities of the study being undertaken. A variety of injectable pharmaceuticals useful for the narcosis of laboratory rats is presented in Table 4.2. 3 ,​ 4 ,​ 5 ,​ 6 ,​ 7 ,​ 8 ,​ 9 Metabolism is higher in rodents than in humans, and drugs are therefore metabolized and excreted faster. Thus, dosages for anesthetics differ significantly from those for humans. Many substances are narcotics and require special permission and conditions for their storage and use.


For rat anesthesia during microsurgical training, we prefer using a xylazine/ketamine cocktail. The recommended combination is 8 mL of 100 mg/mL ketamine + 1 mL of 100 mg/mL xylazine + 1 mL of sterile isotonic saline, resulting in 10 mL total cocktail. The dosage of 0.1 mL per 100 g intramuscular injection delivers 10 mg/kg xylazine and 80 mg/kg ketamine.


Laboratory animals are small in size, so the volume of injected solution is small (Table 4.3). For aqueous solutions, intramuscular injection sites should be rotated. For nonaqueous solutions, not more than two intramuscular injection sites and not more than three subcutaneous injection sites should be used per day. 10 Intraperitoneal injections should be infrequent in survival experiments due to the risk of peritonitis.
















































































































Table 4.2 Injectable anesthetics and application doses for rats

Drug


Trade names


Dose


Effect


Duration, minute


Sleep, minute


Reference


Ketamine + acepromazine

 

30–75 mg/kg + 2.5–3 mg/kg IM or IP


Light anesthesia


20–30


120


3 ,​ 5


Ketamine/diazepam


Valium


40–80 mg/kg + 5–10 mg/kg IP


Light anesthesia


20–30


120


3 ,​ 5


Ketamine + dexmedetomidine


Dexdomitor


60–80 mg/kg + 0.1–0.25 mg/kg IP


Surgical anesthesia,


dexmedetomidine should not be re-dosed


20–30


120–240


3 ,​ 4


Ketamine + midazolam


Versed


60–80 mg/kg + 5 mg/kg IP


Light anesthesia


20–30


120


3 ,​ 5


Ketamine + xylazine


Rompun


50–100 mg/kg + 5–10 mg/kg IP or IM


Surgical anesthesia, xylazine should not be re-dosed


20–30


120–240


3 ,​ 7


Methohexital 1% solution


Brevital


7–15 mg/kg IV


Light anesthesia


5


10


6


Pentobarbital


Nembutal


30–60 mg/kg IP


Light anesthesia


15–60


120–240


3 ,​ 7 ,​ 8


Propofol


Diprivan,


Rapinovet


7.5–10 mg/kg IV (induction); 44–55 mg/kg/h (maintenance)


Surgical anesthesia


5


10


3 ,​ 6


Thiopental


Pentothal


30 mg/kg IV; 50 mg/kg IP


Surgical anesthesia


10


15


3 ,​ 5


Tiletamine/zolazepam


Telazol


20–40 mg/kg IP or


20 mg/kg IM


Light anesthesia


15–25


60–120


9


Urethanea

 

1,000 mg/kg IP


Surgical anesthesia


360–480


60–120


3


Abbreviations: IM, intramuscular; IP, intraperitoneal; IV, intravenous.


aTumor inducer; use only in nonrecovery experiments.


















































Table 4.3 Administration volumes considered good practice (and possible maximal dose volumes)

Species


Route, volumes, mL/kga


Oral


SC


IP


IM


IV (bolus)


IV (slow injection)


Mice


10 (50)


10 (40)


20 (80)


0.05b (0.1)b


5


(25)


Rat


10 (40)


5 (10)


10 (20)


0.1b (0.2)b


5


(20)


Rabbits


10 (15)


1 (2)


5 (20)


0.25 (0.5)


2


(10)


Abbreviations: IM, intramuscular; IP, intraperitoneal; IV, intravenous; SC, subcutaneous.


aNumbers in parentheses represent possible maximal dose volumes.


bmL/site


Source: Adapted from Diehl et al. 10

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jul 21, 2020 | Posted by in NEUROSURGERY | Comments Off on 4 Day 3: Wet-Laboratory Microsurgical Training: Basic Principles for Working with Laboratory Animals

Full access? Get Clinical Tree

Get Clinical Tree app for offline access